Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Moderate-to-Severe Atopic Dermatitis. Show all posts
Showing posts with label Moderate-to-Severe Atopic Dermatitis. Show all posts
Monday, March 7, 2022

FDA Approves Cibinqo (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis

›
Pfizer Inc. (NYSE: PFE) announced  the United States (U.S.) Food and Drug Administration (FDA) approval of   Cibinqo  (abrocitinib), an oral...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.